Calendar

Week of Apr 20, 2026

Apr 24, 2026phase 3 completion74d agoChong Kun Dang Pharmaceutical Corp. — CKD-398 (Phase III Trial Completion)CKD-398

Therapy area: Metabolic Disorders. Indication: Type 2 Diabetes

Apr 24, 2026phase 3 completion74d agoImmuneOnco Biopharmaceuticals (Shanghai) Co Ltd — timdarpacept (Phase III Trial Completion)timdarpacept

Therapy area: Oncology. Indication: Chronic Myelomonocytic Leukemia (CMML)

full page →timdarpacept →source: globaldata

Apr 24, 2026phase 3 completion74d agoBioClever 2005 SL — minoxidil (Phase III Trial Completion)minoxidil

Therapy area: Dermatology. Indication: Androgenic Alopecia

full page →minoxidil →source: globaldata

Apr 24, 2026phase 3 completion74d agoShriners Hospitals for Children — bupivacaine ER (Phase III Trial Completion)bupivacaine

Therapy area: Central Nervous System, Mouth and Dental Disorders. Indication: Post-Operative Pain, Unspecified Mouth and Dental Disorders

full page →bupivacaine →source: globaldata

Apr 25, 2026phase 3 completion73d agoMashhad University of Medical Sciences — acetazolamide (Phase III Trial Completion)ACETAZOLAMIDE

Therapy area: Central Nervous System. Indication: Epilepsy

full page →ACETAZOLAMIDE →source: globaldata

Apr 25, 2026phase 3 completion73d agoAin Shams University — lidocaine (Phase III Trial Completion)LIDOCAINE

Therapy area: Central Nervous System. Indication: Post-Operative Pain

full page →LIDOCAINE →source: globaldata

Apr 26, 2026phase 3 completion72d agoBharatiya Sanskriti Darshan Trust — ayurvedic medicine (Phase III Trial Completion)ayurvedic medicine

Therapy area: Metabolic Disorders. Indication: Type 2 Diabetes

full page →ayurvedic medicine →source: globaldata

Apr 26, 2026phase 3 completion72d agoHomi Bhabha Cancer Hospital Research Centre — megestrol (Phase III Trial Completion)megestrol

Therapy area: Central Nervous System, Gastrointestinal, Genito Urinary System, Respiratory. Indication: Anorexia Nervosa, Unspecified Gastrointestinal Disorders, Unspecified Genito Urinary Disorders, Unspecified Respiratory Disorders

full page →megestrol →source: globaldata

Apr 26, 2026phase 3 completion72d agoHubei Provincial Center for Disease Control and Prevention — rabies vaccine (Phase III Trial Completion)rabies vaccine

Therapy area: Infectious Disease. Indication: Rabies

full page →rabies vaccine →source: globaldata

Apr 26, 2026phase 3 completion72d agoTehran University of Medical Sciences — diltiazem (Phase III Trial Completion)diltiazem

Therapy area: Cardiovascular. Indication: Unspecified Cardiovascular Disorders

full page →diltiazem →source: globaldata

Week of Apr 27, 2026

Apr 27, 2026phase 3 completion71d agoCellCarta Biosciences Inc — elranatamab (Phase III Trial Completion)elranatamab

Therapy area: Oncology. Indication: Multiple Myeloma (Kahler Disease), Refractory Multiple Myeloma, Relapsed Multiple Myeloma

full page →elranatamab →source: globaldata

Apr 27, 2026phase 3 completion

Week of Apr 20, 2026

Week of Apr 27, 2026